Nath Bio-Genes (India) Ltd. Financial Overview
Nath Bio-Genes (India) Ltd.'s market cap is currently ₹2.90B. The company's EPS TTM is ₹2.535; its P/E ratio is 6.93; and it has a dividend yield of 1.33%. Nath Bio-Genes (India) Ltd. is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
